These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4093204)

  • 1. Serum concentrations of mebendazole in patients with hydatid disease.
    Bekhti A
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):633-41. PubMed ID: 4093204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results.
    Münst GJ; Karlaganis G; Bircher J
    Eur J Clin Pharmacol; 1980 May; 17(5):375-8. PubMed ID: 7418715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined chemotherapy (mebendazole plus praziquantel) in patients with hydatidosis].
    Salto E; Juárez E; Roiz MP; Abad J
    Enferm Infecc Microbiol Clin; 1991 Nov; 9(9):527-9. PubMed ID: 1822703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlation between serum mebendazole concentrations and the aminopyrine breath test. Implications in the treatment of hydatid disease.
    Bekhti A; Pirotte J; Woestenborghs R
    Br J Clin Pharmacol; 1986 Feb; 21(2):223-6. PubMed ID: 3082346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions.
    Luder PJ; Siffert B; Witassek F; Meister F; Bircher J
    Eur J Clin Pharmacol; 1986; 31(4):443-8. PubMed ID: 3816925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine increases serum mebendazole concentrations. Implications for treatment of hepatic hydatid cysts.
    Bekhti A; Pirotte J
    Br J Clin Pharmacol; 1987 Sep; 24(3):390-2. PubMed ID: 3663452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of human echinococcosis with mebendazole. Preliminary observations in 28 patients.
    Müller E; Akovbiantz A; Ammann RW; Bircher J; Eckert J; Wissler K; Witassek F; Wüthrich B
    Hepatogastroenterology; 1982 Dec; 29(6):236-9. PubMed ID: 6759344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mebendazole concentrations in sheep plasma.
    Behm CA; Cornish RA; Bryant C
    Res Vet Sci; 1983 Jan; 34(1):37-41. PubMed ID: 6836179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The enhanced bioavailability of mebendazole in echinococcosis patients when used with Essentiale].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1993; (1):43-5. PubMed ID: 8336653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative treatment of hydatid cysts with mebendazole.
    Ronconi P; Borzone A; Alquati P; Pittiruti M
    Int Surg; 1982; 67(4 Suppl):405-6. PubMed ID: 7183592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of peritoneal hydatidosis with mebendazole. Preliminary study (author's transl)].
    García Mérida M; Iglesia P; Esteban JA; Alba J
    An Esp Pediatr; 1981 Mar; 14(3):160-7. PubMed ID: 7271085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease.
    Braithwaite PA; Roberts MS; Allan RJ; Watson TR
    Eur J Clin Pharmacol; 1982; 22(2):161-9. PubMed ID: 7094986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cystic hydatid disease: treatment with interrupted courses of mebendazole.
    Mousa AM; Rudwan MA; Marafi AA; Muhtaseb SA; Dajani AI
    J Trop Med Hyg; 1986 Oct; 89(5):257-64. PubMed ID: 3795326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hepatic and intra-abdominal hydatidosis with mebendazole: prospective comparison of the cyclic and the continuous regimen].
    Gil Grande LA; Sánchez Ruano JJ; López San Román A; García-Hoz F; Barcena R; Salinas F
    Rev Esp Enferm Dig; 1993 Dec; 84(6):386-9. PubMed ID: 8129993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity of mebendazole. Relationship with serum concentrations of the drug.
    Bekhti A; Pirotte J
    Gastroenterol Clin Biol; 1987 Oct; 11(10):701-3. PubMed ID: 3692093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.